Legal Medicine
Volume 5, Issue 1 , Pages 42-48 , March 2003

Immunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusers

Received 17 December 2002 ,Revised 10 January 2003 ,Accepted 14 January 2003.

References 

  1. Nagata T. Signification of methamphetamine concentration in body fluids and tissues (in Japanese). Jpn J Legal Med. 1983;37:513–518
  2. Fujitani N, Matoba R, Shikata I, Yamada T, Mitsukuni Y, Funahashi M. A statistical and histopathological study of autopsy cases of methamphetamine abusers in Osaka from 1977 to 1986 (in Japanese). Res Pract Forens Med. 1990;33:127–132
  3. Mizusawa I, Matsuo Y, Endo T, Aoki K, Kuroiwa Y, Hiraiwa K. Statistical and histopathological studies on autopsy cases of methamphetamine abusers for recent 5 years (in Japanese). Res Pract Forens Med. 1993;36:283–290
  4. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996;17:155–162
  5. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44:359–368
  6. de Gans J, Stam J, van Wijngaarden GK. Rhabdomyolysis and concomitant neurological lesions after intravenous heroin abuse. J Neurol Neurosurg Psychiatry. 1985;48:1057–1059
  7. Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol. 1999;20:120–127
  8. Richards JR. Rhabdomyolysis and drugs of abuse. J Emerg Med. 2000;19:51–56
  9. Kendrick WC, Hull AR, Knochel JP. Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med. 1977;86:381–387
  10. Richards JR, Johnson EB, Stark RW, Derlet RW. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med. 1999;17:681–685
  11. Terada Y, Shinohara S, Matui N, Ida T. Amphetamine-induced myoglobinuric acute renal failure. Jpn J Med. 1988;27:305–308
  12. Ramcharan S, Meenhorst PL, Otten JM, Koks CH, de Boer D, Maes RA, et al. Survival after massive ecstasy overdose. J Toxicol Clin Toxicol. 1998;36:727–731
  13. Lan KC, Lin YF, Yu FC, Lin CS, Chu P. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc. 1998;97:528–533
  14. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol. 2000;8:72–76
  15. Lu D, Das DK. Induction of differential heat shock gene expression in heart, lung, brain and kidney by a sympathomimetic drug, amphetamine. Biochem Biophys Res Commun. 1993;192:808–812
  16. Venkataseshan VS, Marquet E. Heat shock protein 72/73 in normal and diseased kidneys. Nephron. 1996;73:442–449
  17. Kuperman DI, Freyaldenhoven TE, Schmued LC, Ali SF. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction. Brain Res. 1997;771:221–227
  18. Chen HC, Guh JY, Tsai JH, Lai YH. Induction of heat shock protein 70 protects mesangial cells against oxidative injury. Kidney Int. 1999;56:1270–1273
  19. Jayakumar J, Suzuki K, Sammut IA, Smolenski RT, Khan M, Latif N, et al. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation. 2001;104(Suppl. I):I303–I307
  20. Maki A, Berezesky IK, Fargnoli J, Holbrook NJ, Trump BF. Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J. 1992;6:919–924
  21. Megyesi J, Di Mari J, Udvarhelyi N, Price PM, Safirstein R. DNA synthesis is dissociated from the immediate-early gene response in the post-ischemic kidney. Kidney Int. 1995;48:1451–1458
  22. Joannidis M, Cantley LG, Spokes K, Stuart-Tilley AK, Alper SL, Epstein FH. Modulation of c-fos and egr-1 expression in the isolated perfused kidney by agents that alter tubular work. Kidney Int. 1997;52:130–139
  23. Grembowicz KP, Sprague D, McNeil PL. Temporary disruption of the plasma membrane is required for c-fos expression in response to mechanical stress. Mol Biol Cell. 1999;10:1247–1257
  24. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol. 1999;162:196–203
  25. Meldrum DR, Donnahoo KK. Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a post bypass cardiorenal syndrome. J Surg Res. 1999;85:185–199
  26. Takahashi S, Hirose M, Tamano S, Ozaki M, Orita S, Ito T, et al. Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in paraffin-embedded sections of rat liver after carbon tetrachloride treatment. Toxicol Pathol. 1998;26:247–252
  27. Cui J, Holmes EH, Liu PK. Oxidative damage to the c-fos gene and reduction of its transcription after focal cerebral ischemia. J Neurochem. 1999;73:1164–1174
  28. Yamagami K, Yamamoto Y, Kume M, Ishikawa Y, Yamaoka Y, Hiai H, et al. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in rat liver after ischemia-reperfusion: distinct localization of the two oxidatively modified products. Antioxid Redox Signal. 2000;2:127–136
  29. Irie M, Asami S, Nagata S, Miyata M, Kasai H. Classical conditioning of oxidative DNA damage in rats. Neurosci Lett. 2000;288:13–16
  30. Vijayaraghavan M, Wanibuchi H, Karim R, Yamamoto S, Masuda C, Nakae D, et al. Dimethylarsinic acid induces 8-hydroxy-2′-deoxyguanosine formation in the kidney of NCI-Black-Reiter rats. Cancer Lett. 2001;165:11–17
  31. Hoglen NC, Younis HS, Hartley DP, Gunawardhana L, Lantz RC, Sipes IG. 1,2-Dichlorobenzene-induced lipid peroxidation in male Fischer 344 rats is Kupffer cell dependent. Toxicol Sci. 1998;46:376–385
  32. McKracken E, Graham DI, Nilsen M, Stewart J, Nicoll JA, Horsburgh K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 2001;11:414–421
  33. Wang JS, Ger LP, Tseng HH. Expression of glomerular antioxidant enzymes in human glomerulonephritis. Nephron. 1997;76:32–38
  34. Abe M, Saitoh H, Sato Y, Hamaguchi K, Kiuchi M. Immunohistochemical study of the kidneys after severe muscular injury. Int J Legal Med. 2001;114:232–236
  35. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:F948–F957
  36. Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med. 1994;24:68–76
  37. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988;255:F539–F544
  38. Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem. 1998;273:31731–31737
  39. Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ, et al. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet. 1999;353:1241
  40. Acikgoz O, Gonenc S, Kayatekin BM, Uysal N, Pekcetin C, Semin I, et al. Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res. 1998;813:200–202
  41. Yamamoto BK, Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther. 1998;287:107–114

PII: S1344-6223(03)00005-1

Legal Medicine
Volume 5, Issue 1 , Pages 42-48 , March 2003

Article Tools

* Image Usage & Resolution